SCHEMBL24335889

SCHEMBL24335889

Nc1ncc2cc(-c3cccnc3)ccc2n1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIK3CA P42336 2/20 0.55
▸ LCK P06239 1/20 0.55
▸ KDR P35968 1/20 0.55
▸ JAK3 P52333 1/20 0.55
▸ MAPK14 Q16539 1/20 0.55
▸ PIK3CD O00329 1/20 0.55
▸ PIP5K1C O60331 1/20 0.55
▸ PI4KA P42356 1/20 0.55
▸ PI4KB Q9UBF8 1/20 0.55
▸ CYP11B1 P15538 5/20 0.54
▸ CYP11B2 P19099 5/20 0.54
▸ CYP19A1 P11511 4/20 0.54
▸ CYP17A1 P05093 2/20 0.54
▸ MEN1 O00255 1/20 0.51
▸ PSIP1 O75475 1/20 0.51
▸ AXL P30530 1/20 0.51
▸ MKNK1 Q9BUB5 1/20 0.51
▸ MKNK2 Q9HBH9 1/20 0.51
▸ HSP90AA1 P07900 1/20 0.51
▸ HSP90AB1 P08238 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2741576 0.83 LCK (0.65) PIK3CALCKKDRJAK3MAPK14
SCHEMBL3025007 0.82 LCK (0.55) PIK3CALCKKDRJAK3MAPK14
SCHEMBL5488838 0.81 MAP4K4 (0.61) LCKKDRJAK3MAPK14MEN1
SCHEMBL5494272 0.78 LCK (0.58) LCKKDRJAK3MAPK14MEN1
SCHEMBL17803857 0.78 LCK (0.62) LCKKDRJAK3MAPK14PDGFRA
SCHEMBL12575968 0.78 SRC (0.61) PIK3CALCKKDRJAK3MAPK14
SCHEMBL30669824 0.78 PIK3CA (0.62) PIK3CAPIK3CDPIP5K1CPI4KAPI4KB
SCHEMBL27892456 0.78 PIK3CA (0.62) PIK3CAPIK3CDPIP5K1CPI4KAPI4KB
SCHEMBL21264426 0.77 NPC1 (0.75) PIK3CAPIK3CDPIP5K1CPI4KAPI4KB
SCHEMBL30604173 0.77 NPC1 (0.75) PIK3CAPIK3CDPIP5K1CPI4KAPI4KB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3395814-B1 INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR BLUEPRINT MEDICINES CORP (US) 2022-04-06 — — EP disclosed
Send feedback